Nuevolution is a biopharmaceutical company listed on Nasdaq Stockholm (Small Cap), focused on developing drug treatments for human diseases within immuno-oncology, oncology and inflammatory diseases.
Augment carried out a block trade of shares.
2 January 2019
Nuevolution is a biopharmaceutical company listed on Nasdaq Stockholm (Small Cap), focused on developing drug treatments for human diseases within immuno-oncology, oncology and inflammatory diseases.
Augment carried out a block trade of shares.